Home
>
Assessments
>
Microvolt T-Wave Alternans Testing to Risk Stratify Patients for Implantable Cardioverter-Defibrillator Placement for Prevention of Sudden Cardiac Death
Microvolt T-Wave Alternans Testing to Risk Stratify Patients for Implantable Cardioverter-Defibrillator Placement for Prevention of Sudden Cardiac Death
| Please note: All assessments are current as of the review date; however, new evidence that may have been published subsequently is not considered. |
| Review Date: |
October 18, 2006 |
| Recommendation: |
This topic was reviewed by the California Technology Assessment Forum on October 18, 2006. It was recommended that the use of Microvolt T-Wave Alternans testing to risk stratify patients for implantable cardioverter-defibrillator placement for prevention of sudden cardiac death does not meet CTAF Criteria because it is unclear as of yet how to use this test to improve medical management in a way that will benefit the patient. |
| Decision: |
Does Not Meet CTAF Criteria |
| Full Assessment: |
Download (PDF) |
|
